Literature DB >> 1841038

Effect of cyclosporin A on B cell maturation and differentiation.

M T Lun1, S Cochi, D Fioravanti, C Nazzari, G Raponi, E Mannella, G Di Tommaso, C Mancini, F Filadoro.   

Abstract

The activation and differentiation of resting B cells into Ig secreting cells are regulated by T cells, macrophages and their secreted factors. The present study evaluated the effect of cyclosporin A (CsA) on this process. Peripheral blood lymphomonocytes (PBMC) drawn from healthy donors were stimulated with protein A (PA) or with lipopolysaccharides plus pokeweed (LPS+PWM) in either the presence or the absence of CsA. Phenotypic B cell changes and immunoglobulin production was then analyzed. The data revealed that CsA decreased the expression of B cell surface receptors of the activation phase, and enhanced the resting phase receptors. Different effects of CsA were found on B cell differentiation, depending on its induction by PA or LPS+PWM. In the first system, CsA decreased the expression of differentiation phase receptors and the secretion of free Ig. In cultures stimulated with LPS+PWM, CsA increased the differentiated phase receptors and Ig secretion. Thus, CsA seemed to act as a blocking agent of the activation phase and as a modulator of the differentiation phase and of IgG secretion, depending upon the antigen used for stimulation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1841038

Source DB:  PubMed          Journal:  Drugs Exp Clin Res        ISSN: 0378-6501


  2 in total

1.  Immunopathologic Effects of Prednisolone and Cyclosporine A on Feline Immunodeficiency Virus Replication and Persistence.

Authors:  Craig Miller; Jordan Powers; Esther Musselman; Ryan Mackie; John Elder; Sue VandeWoude
Journal:  Viruses       Date:  2019-08-30       Impact factor: 5.048

2.  Treatment of ligneous conjunctivitis with amniotic membrane transplantation and topical cyclosporine.

Authors:  Ozlem Yalcin Tok; Fatma Akbas Kocaoglu; Levent Tok; Ayse Burcu; Firdevs Ornek
Journal:  Indian J Ophthalmol       Date:  2012 Nov-Dec       Impact factor: 1.848

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.